Park National Corp OH Boosts Johnson & Johnson Stock Holdings

Institutional investor increases stake in pharmaceutical giant by 24.3% in Q4 2025

Mar. 21, 2026 at 9:57am

Park National Corp OH, an institutional investor, increased its position in Johnson & Johnson (NYSE: JNJ) by 24.3% in the fourth quarter of 2025, according to a recent SEC filing. The firm now owns 118,637 shares of the company's stock, valued at $24,552,000 as of the end of the quarter.

Why it matters

Johnson & Johnson is a major pharmaceutical and consumer healthcare company, and changes in institutional ownership of its stock can provide insights into investor sentiment and market trends around the company. The increase in Park National Corp OH's stake suggests confidence in J&J's performance and growth prospects.

The details

According to the SEC filing, Park National Corp OH acquired an additional 23,165 shares of Johnson & Johnson during the fourth quarter, bringing its total holdings to 118,637 shares. This represents a 24.3% increase in the firm's position compared to the previous quarter.

  • Park National Corp OH filed the SEC report on March 21, 2026.

The players

Park National Corp OH

An institutional investor and hedge fund based in Ohio.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

The increase in Park National Corp OH's stake in Johnson & Johnson suggests continued investor confidence in the company's long-term growth and performance, despite any short-term market fluctuations.